A growing number of Americans suffering from chronic nerve pain, tingling, and numbness have begun searching for natural ...
Company positions itself as the central research hub for patients, clinicians, and compounding pharmacies tracking the ...
The ruling revives rules set by the Department of State Health Services in 2021 that classify Delta-8 as an illegal substance ...
A new study links toxic compounds in false morel mushrooms to a rare cluster of ALS cases, raising urgent questions about ...
A new Consumer Reports analysis is taking a closer look at what’s actually inside hair dye kits and what it could mean for ...
The US FDA has proposed an end to most types of compounding of semaglutide, tirzepatide, and liraglutide. The agency said in a statement it has determined there is no longer a clinical need for ...
Bans on older versions of “forever chemicals” seem to be working. But emerging variants behave in ways that scientists are ...
A study has revealed that galloylquinic acids extracted from the leaves of Copaifera lucens Dwyer, a tree endemic to Brazil ...
FDA seeks restrict compounding of GLP-1 drugs by excluding semaglutide, tirzepatide and liraglutide from the 503B bulks list to limit unauthorized use.
FDA officials tested more than 300 samples of commercial infant formula between 2023 and 2025 for heavy metals, including ...
The U.S. Food and Drug Administration on ‌Thursday proposed excluding active ingredients ‌for Novo Nordisk and Eli Lilly's ...
Store-bought hair dyes have been a go-to for decades, but they can sometimes come with unwanted side effects. Some users ...